You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CYSTADANE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cystadane, and what generic alternatives are available?

Cystadane is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in CYSTADANE is betaine. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the betaine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cystadane

A generic version of CYSTADANE was approved as betaine by NOVITIUM PHARMA on November 23rd, 2021.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CYSTADANE?
  • What are the global sales for CYSTADANE?
  • What is Average Wholesale Price for CYSTADANE?
Summary for CYSTADANE
Drug patent expirations by year for CYSTADANE
Drug Prices for CYSTADANE

See drug prices for CYSTADANE

Recent Clinical Trials for CYSTADANE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
McGill University Health Centre/Research Institute of the McGill University Health CentrePhase 2
McGill University Health CenterPhase 2
March of DimesPhase 2

See all CYSTADANE clinical trials

Pharmacology for CYSTADANE
Drug ClassMethylating Agent
Mechanism of ActionMethylating Activity

US Patents and Regulatory Information for CYSTADANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare CYSTADANE betaine FOR SOLUTION;ORAL 020576-001 Oct 25, 1996 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.